Thanks@Jase99 ,
As you say ... “massive potential benefit to usingPD1-Vaxx prior to surgery is that the immune system will continue producing the antibodies post-surgery”
PD1-Vaxx may be the gift that keeps giving. In many cases, it could be the difference between the disease returning ... or not. Critical.
Hi @Steini ,
You ask ... “So, why isn't there any recognition from pharma or funds?”
A very good questions and asked by many on these threads.
My personal belief (I have no inside info), is that in bio-tech it is ALWAYS ‘First in Best Dressed’ or, the first to gain approval can only be superseded by a far, far superior treatment. It is often not enough to be safer, but with similar efficacy. Just my opinion though.
By the way, why do you refer to yourself as ... “Downramper and Bedwetter" - Steini. ??
I find your post always thoughtful, even if some here disagree with your sentiment. It’s an open and free forum after all.
Hi @LHI 14 ,
Yes, yes and yes.You nail it ... “Preoperative MRI staging of rectal cancer gives an accurate definition of tumour size, invasion, but also vascular and lymph node involvement.” Any surgeon will greatly appreciate this information. Knowledge is not just power but critical to the success of difficult procedures.
You go on ... “I am keen to see the results (when it starts), of the histology on the resected specimen, and whether there is evidence of any tumour regression, or other effects, in lymph nodes studied.”
I definitely would love to see these data also, but ... I not sure just how much will find its way to us. IMU have not designed the endpoints (as far as I am aware), so I guess we will take what we get. Fingers crossed.
PS to@SteelDragon
Your reply to Dingo did make me chuckle ... “A post from someone who has been well fed.
- anyone missing a baby?”
I do appreciate a little dark humour.
Humour is something that has been missing from these threads for a while, and I get why.
Bring on the data !!
(20min delay)